Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).

ChEIs produce small, short-term improvements in the cognitive function of patients with mild to moderate dementia, which can result in statistically significant changes, but only marginally significant clinical improvements in cognition and global assessment scores.

also in 5,076 other papers